XML 14 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES      
Net loss $ (7,692) $ (13,215)  
Adjustments to reconcile net loss to net cash used by operating activities      
Depreciation and amortization 1,501 1,254  
Provision for warranty expense (552)    
Non-cash lease expense 375 299  
Stock-based compensation related to acquisition   109  
Stock-based compensation 3,281 3,571  
Compensation expense related to acquisition 137 1,625  
Change in fair value of earnout related to acquisition 80 141  
Non-cash interest expense 39 32  
Provision for excess and obsolete inventory 96 (60)  
Provision for doubtful accounts 1,181 (89)  
Non-cash legal accrual (Note 12 "Commitments and Contingencies") 4,955    
Change in operating assets and liabilities      
Accounts receivable 2,701 3,483  
Inventory 5,612 8,949  
Deferred cost of revenue 2,726 3,294  
Prepaid expenses and other assets 349 (4,577)  
Accounts payable (7,448) (6,661)  
Accrued expenses and other liabilities (6,673) (11,129)  
Deferred revenue (3,591) 3,011  
Lease liabilities (414) (327)  
Net cash used in operating activities (3,337) (10,290)  
CASH FLOWS FROM INVESTING ACTIVITIES      
Purchase of property and equipment (34) (27)  
Capitalized software costs (922) (1,142)  
Net cash used in investing activities (956) (1,169)  
CASH FLOWS FROM FINANCING ACTIVITIES      
Payments for repurchases of Class A common stock (4,373)    
Proceeds from options exercise 2 71  
Proceeds from ESPP purchases 337 438  
Taxes paid related to net share settlements of stock-based compensation awards (898) (661)  
Payment of earnout related to acquisition (1,530) (1,702)  
Net cash used in financing activities (6,462) (1,854)  
Effect of exchange rate changes on cash and cash equivalents (6) 27  
Net decrease (increase) in cash, cash equivalents, and restricted cash (10,761) (13,286)  
Cash, cash equivalents, and restricted cash - beginning of period 215,709 217,713 $ 217,713
Cash, cash equivalents, and restricted cash - end of period 204,948 204,427 215,709
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets      
Cash and cash equivalents 204,701 203,933 215,214
Restricted cash, current portion 247 247 495
Restricted cash, included in other long-term assets   247  
Total cash, cash equivalents, and restricted cash 204,948 204,427 $ 215,709
Supplemental disclosure of cash flow information      
Interest paid 72 70  
Cash paid for income taxes 6    
Schedule of non-cash investing and financing activities      
Accrued property and equipment at period end 81 $ 8  
Stock repurchases excise tax charged to equity $ 24